Clinical Trials Browser

Phase 1/2 × OTHER × Tenofovir × Clear all

NCT07133776 2025-08-21

Application of PD-1 Inhibitors Combined With Tenofovir, Chidamide and Lenalidomide in the Treatment of EBV-associated Diseases.

Phase 1/2 Not yet recruiting

Infections, Epstein-Barr Virus Infections

NCT01528865 2016-03-11

Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma

Phase 1/2 Withdrawn

Lymphoma, Virus Diseases